Morphological study of chronic prostatitis–chronic pelvic pain syndrome (CP/CPPS) normal modeling dose of T2 peptide in mice

[1]  M. Sohail,et al.  Morphological reseach on expression of inflammatory mediators in murine models of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) induced by T2 antigen , 2019, Andrologia.

[2]  R. Ullah,et al.  Effect of Oral T2 Antigen on Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Mice Model , 2019, Inflammation.

[3]  A. Ihsan,et al.  A nanoparticle‐coupled T2 peptide induces immune tolerance and ameliorates chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in mice model , 2019, Fundamental & clinical pharmacology.

[4]  Reyaj Mikrani,et al.  Novel Treatment of Experimental Autoimmune Prostatitis by Nanoparticle-Conjugated Autoantigen Peptide T2 , 2019, Inflammation.

[5]  M. Baig,et al.  Experimental rodent models of chronic prostatitis and evaluation criteria. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  G. Wang,et al.  A novel mouse model of chronic prostatitis/chronic pelvic pain syndrome induced by immunization of special peptide fragment with aluminum hydroxide adjuvant. , 2017, Immunology letters.

[7]  Zhou Wang,et al.  MP25-07 PROSTATIC INFLAMMATION EVOKES UPREGULATION OF NEUROTROPHINS IN SENSORY GANGLIA: POSSIBLE CONTRIBUTION TO DYSFUNCTIONAL VOIDING , 2015 .

[8]  A. Schaeffer,et al.  Immune mediators of chronic pelvic pain syndrome , 2014, Nature Reviews Urology.

[9]  J. Ramon,et al.  Authors and Affiliations , 2014 .

[10]  J. Attia,et al.  α‐blockers, antibiotics and anti‐inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome , 2012, BJU international.

[11]  R. Alexander,et al.  T-cell recognition of prostatic peptides in men with chronic prostatitis/chronic pelvic pain syndrome. , 2009, The Journal of urology.

[12]  A. Schaeffer,et al.  Prostatitis/chronic pelvic pain syndrome. , 2006, Annual review of medicine.

[13]  J. Ku,et al.  Chronic prostatitis in Korea: a nationwide postal survey of practicing urologists in 2004. , 2005, Asian journal of andrology.

[14]  A. Schaeffer,et al.  Summary consensus statement: Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome , 2003 .

[15]  A. Doble,et al.  Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS) , 2002, Clinical and experimental immunology.

[16]  M. Altmannsberger,et al.  Immunocytological Analysis of Leukocyte Subpopulations in Urine Specimens before and after Prostatic Massage , 2001, European Urology.

[17]  V. Rivero,et al.  Non-obese diabetic (NOD) mice are genetically susceptible to experimental autoimmune prostatitis (EAP). , 1998, Journal of autoimmunity.

[18]  M. Barry,et al.  How common is prostatitis? A national survey of physician visits. , 1998, The Journal of urology.

[19]  D. Bostwick,et al.  Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. , 1998, Urology.

[20]  J. Heiman,et al.  Sickness impact of chronic nonbacterial prostatitis and its correlates. , 1996, The Journal of urology.

[21]  P. Humphrey,et al.  Development of a mouse model for nonbacterial prostatitis. , 1994, The Journal of urology.

[22]  C. Smith,et al.  Cytomegalovirus prostatitis. , 1992, Urology.